Cargando…
Is Li-ESWT effective in diabetic patients with severe erectile dysfunction?
Noninvasive low-intensity extracorporeal shockwave treatment (Li-ESWT) has been widely used to treat erection disorders. There is no clear information regarding either the selection of patients for the treatment or the treatment protocol. In this study, we aimed to investigate the efficacy of extrac...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491027/ https://www.ncbi.nlm.nih.gov/pubmed/35042309 http://dx.doi.org/10.4103/aja2021105 |
_version_ | 1784793206774300672 |
---|---|
author | Ergün, Müslüm Akyüz, Osman |
author_facet | Ergün, Müslüm Akyüz, Osman |
author_sort | Ergün, Müslüm |
collection | PubMed |
description | Noninvasive low-intensity extracorporeal shockwave treatment (Li-ESWT) has been widely used to treat erection disorders. There is no clear information regarding either the selection of patients for the treatment or the treatment protocol. In this study, we aimed to investigate the efficacy of extracorporeal shockwave therapy in diabetic patients with severe erectile dysfunction (International Index of Erectile Function-5 [IIEF-5] scores of 5 to 7). Sixty-three diabetes mellitus patients with erectile dysfunction having IIEF-5 scores of 5 to 7 and not showing a recovery of potency despite phosphodiesterase type 5 inhibitor therapy for the past 6 months were included in the study. The patients were evaluated based on their IIEF-5 scores and Erection Hardness Scale scores. The IIEF-5 score (mean ± standard deviation [s.d.]) increased from 5.29 ± 1.67 to 5.56 ± 1.85, with a difference of 0.27 ± 0.18 (P > 0.05). The Erection Hardness Scale scores (mean ± s.d.), on the other hand, increased from 1.46 ± 0.50 to 1.48 ± 0.50, with a difference of 0.02 ± 0 (P > 0.05). In conclusion, the response to phosphodiesterase type 5 inhibitors did not change after extracorporeal shockwave treatment in diabetes mellitus patients with severe erectile dysfunction (IIEF-5 scores of 5 to 7). |
format | Online Article Text |
id | pubmed-9491027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-94910272022-09-22 Is Li-ESWT effective in diabetic patients with severe erectile dysfunction? Ergün, Müslüm Akyüz, Osman Asian J Androl Original Article Noninvasive low-intensity extracorporeal shockwave treatment (Li-ESWT) has been widely used to treat erection disorders. There is no clear information regarding either the selection of patients for the treatment or the treatment protocol. In this study, we aimed to investigate the efficacy of extracorporeal shockwave therapy in diabetic patients with severe erectile dysfunction (International Index of Erectile Function-5 [IIEF-5] scores of 5 to 7). Sixty-three diabetes mellitus patients with erectile dysfunction having IIEF-5 scores of 5 to 7 and not showing a recovery of potency despite phosphodiesterase type 5 inhibitor therapy for the past 6 months were included in the study. The patients were evaluated based on their IIEF-5 scores and Erection Hardness Scale scores. The IIEF-5 score (mean ± standard deviation [s.d.]) increased from 5.29 ± 1.67 to 5.56 ± 1.85, with a difference of 0.27 ± 0.18 (P > 0.05). The Erection Hardness Scale scores (mean ± s.d.), on the other hand, increased from 1.46 ± 0.50 to 1.48 ± 0.50, with a difference of 0.02 ± 0 (P > 0.05). In conclusion, the response to phosphodiesterase type 5 inhibitors did not change after extracorporeal shockwave treatment in diabetes mellitus patients with severe erectile dysfunction (IIEF-5 scores of 5 to 7). Wolters Kluwer - Medknow 2022-01-14 /pmc/articles/PMC9491027/ /pubmed/35042309 http://dx.doi.org/10.4103/aja2021105 Text en Copyright: ©The Author(s)(2022) https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Ergün, Müslüm Akyüz, Osman Is Li-ESWT effective in diabetic patients with severe erectile dysfunction? |
title | Is Li-ESWT effective in diabetic patients with severe erectile dysfunction? |
title_full | Is Li-ESWT effective in diabetic patients with severe erectile dysfunction? |
title_fullStr | Is Li-ESWT effective in diabetic patients with severe erectile dysfunction? |
title_full_unstemmed | Is Li-ESWT effective in diabetic patients with severe erectile dysfunction? |
title_short | Is Li-ESWT effective in diabetic patients with severe erectile dysfunction? |
title_sort | is li-eswt effective in diabetic patients with severe erectile dysfunction? |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491027/ https://www.ncbi.nlm.nih.gov/pubmed/35042309 http://dx.doi.org/10.4103/aja2021105 |
work_keys_str_mv | AT ergunmuslum islieswteffectiveindiabeticpatientswithsevereerectiledysfunction AT akyuzosman islieswteffectiveindiabeticpatientswithsevereerectiledysfunction |